(Q33186595)

English

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

based on heuristic

inferred from title

author name string

J A Foekens

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Ch Ries

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

M P Look

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

C Gippner-Steppert

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

J G M Klijn

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

M Jochum

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1084-1090

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600813

0 references

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Clinical relevance of the urokinase plasminogen activator system in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

The codependence of angiogenesis and chronic inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Leukocyte elastase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

The elastase-mediated pathway of fibrinolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

21 June 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600813

21 January 2018

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600813

21 January 2018

Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600813

21 January 2018

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

31 October 2018

Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

31 October 2018

The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376381

31 October 2018

Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elastase-released Epidermal Growth Factor Recruits Epidermal Growth Factor Receptor and Extracellular Signal-regulated Kinases to Down-regulate Tropoelastin mRNA in Lung Fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human leukocyte granule elastase: rapid isolation and characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elastogenesis and elastinolytic activity in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha 2-plasmin inhibitor inactivation by human granulocyte elastase

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elastases in human breast carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time dependency of the influence of prognostic factors on relapse in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free-form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis and inflammation in ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12671709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600813

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33186595&oldid=1962220438"